Table 2 Scope of the sequential one-pot ring-opening/coupling
(t, J = 7.6 Hz, 2H), 7.02 (t, J = 7.6 Hz, 1H), 6.96–6.90 (m, 6H),
4.59–4.56 (m, 1H), 4.43 (dd, J = 1.4, 11.4 Hz, 1H), 4.30–4.22 (m,
2H), 4.19–4.15 (m, 1H); 13C NMR (100 MHz, CDCl3): d 158.26,
143.18, 142.91, 129.55, 121.74, 121.53, 121.40, 117.40, 117.25,
114.56, 71.34, 66.24, 65.34; IR: u = 3019, 2930, 2882, 1578, 1493,
1269, 1237, 1076, 745, 689 cm-1.
protocola
Entry
R1
R2
Product/yieldb
Notes and references
1
2
3
4
5
6
7
8
H
H
H
H
H
H
H
H
H
H
H
Me
Me
Me
Me
Cl
H
p-Me
p-t-Bu
m-Me
o-Me
2,4-di-t-Bu
p-Cl
2,4-di-Cl
o-COCH3
p-CHO
2k/naphthol
H
3a/76
3b/79
3c/80
3d/77
3e/73
3f/70
3g/69
3h/57
3i/56
3j/61
3k/59
3l/79
3m/81
3n/77
3o/71
3p/73
1 (a) R. Henning, R. Lattrell, H. J. Gerhards and M. Levent, J. Med.
Chem., 1987, 30, 814; (b) S. Nikam, A. Martin and D. Nelson,
J. Med. Chem., 1988, 31, 1965; (c) M. F. Hibert, M. W. Gittos, D. N.
Moddlemiss, A. K. Mir and J. R. Fozard, J. Med. Chem., 1988, 31,
1087.
2 Y. Satoh, C. Powers, L. M. Toledo, T. J. Kowalski, P. A. Peters and E. F.
Kimble, J. Med. Chem., 1995, 38, 68.
9
3 L. Juha’sz, T. Docsa, A. Brunya’szki, P. Gergely and S. Antus, Bioorg.
Med. Chem., 2007, 15, 4048.
10
11
12
13
14
15
16
4 (a) G. Marciniak, A. Delgado, G. Leclerc, J. Velly, N. Decker and J.
Schwartz, J. Med. Chem., 1989, 32, 1402; (b) Y. Takano, M. Takano
and T. L. Yaksh, Eur. J. Pharmacol., 1992, 219, 465; (c) R. Zhou,
G. Luo and A. G. J. Ewing, Neuroscience, 1994, 14, 2402; (d) R. R.
Ruffolo Jr., W. Bondinell and J. P. Hieble, J. Med. Chem., 1995, 38,
3681.
5 (a) W. S. Woo, S. S. Kang, H. Wagner and V. M. Chari, Tetrahedron
Lett., 1978, 19, 3239; (b) Y. Fukuyama, T. Hasegawa, M. Toda,
M. Kodama and H. Okazaki, Chem. Pharm. Bull., 1992, 40, 252;
(c) N.-C. Kim, T. N. Graf, C. M. Sparacino, M. C. Wani and M. E.
Wall, Org. Biomol. Chem., 2003, 1, 1684; (d) Y.-W. Chin and J. Kim,
Tetrahedron Lett., 2004, 45, 339; (e) D. Sinou, Curr. Org. Chem., 2005, 9,
377.
p-Me
m-Me
p-Cl
H
a Reaction conditions: (2-((o-iodophenoxy)methyl)oxirane (1 mmol), phe-
nol (1.2 mmol), CuBr (15 mol%), 1,10-phenanthroline(30 mol%), Cs2CO3
(2 mmol), in DMA (2 mL) at 120 ◦C for 48 h. b Isolated yield.
were performed using simple and cheap materials while the
products were obtained with considerably increased molecular
complexity as well as a typical structural feature of known bio-
functional scaffolds. More importantly, through the modification
on the reactant structure, the problem of producing isomers
via the nuleophilic attack to different sites of epoxide has been
successfully avoided in the present study. Therefore, this method-
ology is not only a highly useful route for the synthesis of 1,4-
benzodioxane derivatives, but also a guide for improving similar
reactions which suffers from the undesirable regio-sites reactions.
Further study on expanding the application of this system to
the synthesis of analogous heterocycles is presently in progress in
our lab.
6 (a) T. V. Lee, A. J. Leigh and C. B. Chapleo, Tetrahedron, 1990, 46, 921;
(b) P. Moreau, G. Guillaumet and G. Coudert, Synth. Commun., 1994,
24, 1781.
7 (a) J. Koo, S. Avakian and J. G. Martin, J. Am. Chem. Soc., 1955,
77, 5373; (b) S. K. Mallick and J. F. Caputo, J. Org. Chem., 1974, 39,
1808; (c) A. K. Willard, R. L. Smith and E. J. Cragoe, J. Org. Chem.,
1981, 46, 3846; (d) P. A. Procopiou, A. C. Brodie, M. J. Deal and D. F.
Hayman, Tetrahedron Lett., 1988, 29, 3671; (e) M. Massacret, P. Lhoste,
R. Lakhmiri, T. Parella and D. Sinou, Eur. J. Org. Chem., 1999, 2665
and references therein; (f) Y. Harrak, G. Guillaumet and M. D. Pujol,
Synlett, 2003, 813; (g) S. Kim, J. Y. Wu, H. Y. Chen and F. DiNinno,
Org. Lett., 2003, 5, 685.
8 (a) A. B. Basak, G. Bhattachariya, U. K. Mallick and U. K. Khamrai,
Synth. Commun., 1997, 27, 367; (b) C. Chowdhury, G. Chaudhuri, S.
Guha, A. K. Mukherjee and N. G. Kundu, J. Org. Chem., 1998, 63,
1863; (c) J.-R. Labrosse, P. Lhoste and D. Sinou, Org. Lett., 2000, 2,
527.
9 (a) W. M. Horspool, J. M. Tedder and Z. U. Din, J. Chem. Soc. C,
1969, 1692; (b) M. F. Ansell and A. Bignold, J. Chem. Commun., 1969,
1096; (c) A. Dondoni, M. Fogagnolo, A. Mastellari, P. Pedrini and F.
Ugozzoli, Tetrahedron Lett., 1986, 27, 3915; (d) V. Nair, B. Mathew,
K. V. Radhakrishnan and N. P. Rath, Tetrahedron, 1999, 55, 11017;
(e) D. W. Xu, A. Chiaroni and M. Largeron, Org. Lett., 2005, 7,
5723.
Experimental
General procedure for the synthesis of
2-substituted-1,4-benzodioxanes
10 For selected reviews, see: (a) I. P. Beletskaya and A. V. Cheprakov,
Coord. Chem. Rev., 2004, 248, 2337; (b) J. R. Dehli, J. Legros and C.
Bolm, Chem. Commun., 2005, 973.
11 For recent selected one-pot reactions based on copper-catalyzed C–N
coupling, see: (a) B. L. Zou, Q. L. Yuan and D. W. Ma, Org. Lett.,
2007, 9, 4291; (b) X. Y. Yuan, X. B. Xu, X. B. Zhou, J. W. Yuan, L. G.
Mai and Y. Z. Li, J. Org. Chem., 2007, 72, 1510; (c) E. G. Feng, H.
Huang, Y. Zhou, D. J. Ye, H. L. Jiang and H. Liu, J. Org. Chem., 2009,
74, 2846; (d) N. Ibrahim and M. Legraverend, J. Org. Chem., 2009, 74,
363.
12 For recent selected one-pot reactions based on copper-catalyzed C–
C coupling, see: (a) S. Cacchi, G. Fabrizi and L. M. Parisi, Org. Lett.,
2003, 5, 3843; (b) Y. J. Pan, C. P. Holmes and D. Tumelty, J. Org. Chem.,
2005, 70, 4897; (c) S. Tanimori, H. Ura and M. Kirihata, Eur. J. Org.
Chem., 2007, 3977; (d) Y. Chen, Y. J. Wang, Z. M. Sun and D. W. Ma,
Org. Lett., 2008, 10, 625; (e) F. Wang, H. X. Liu, H. Fu, Y. Y. Jiang and
Y. F. Z h a o , Org. Lett., 2009, 11, 2469.
A Schlenk tube was charged with CuBr (22 mg, 15% mol), 1,10-
phenanthroline (57 mg, 30% mol), Cs2CO3 (650 mg, 2 mmol),
phenol (113 mg, 1.2 mmol), evacuated and backfilled with nitro-
gen. Then 2-((2-iodophenoxy)methyl)oxirane (276 mg, 1.0 mmol),
DMA (2 mL) were successively added. The reaction tube was
◦
quickly sealed and the contents were stirred at 120 C for 48 h.
Then the cooled reaction mixture was dissolved in H2O and ex-
tracted with Et2O. The combined organic layer was dried (MgSO4).
The product was further purified by column chromatography
(silica gel, PE-EtOAC).
2-Phenoxymethyl◦-2,3-dihydrobenzo[1,4]dioxin
(3a). White
solid, m.p. 35–36 C3; 1H NMR (400 MHz, CDCl3): d 7.33
2702 | Org. Biomol. Chem., 2010, 8, 2700–2703
This journal is
The Royal Society of Chemistry 2010
©